Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Journal of the American Medical Directors Association
|
June 17, 2003
Quality improvement case study: issues involving elopement of residents
Andrew D Weinberg, Alicia D Weinberg
Critical Reviews in Immunology
|
January 17, 2008
Targeting OX40 and OX40L for the treatment of autoimmunity and cancer
William L Redmond, Andrew D Weinberg
Cancer Immunology, Immunotherapy : CII
|
March 17, 2009
The effect of aging on OX40 agonist-mediated cancer immunotherapy
Carl E Ruby, Andrew D Weinberg
Nature Reviews. Immunology
|
June 3, 2004
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Kazuo Sugamura, Naoto Ishii, Andrew D Weinberg
Cancer Immunology Research
|
December 20, 2018
Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Fanny Polesso, Andrew D Weinberg, Amy E Moran
Immunology
|
May 15, 2012
Targeting macrophages in the tumour environment to enhance the efficacy of αOX40 therapy
Michael J Gough, N Killeen, Andrew D Weinberg
Journal of Immunology (Baltimore, Md. : 1950)
|
August 10, 2016
Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ
Amy E Moran, Fanny Polesso, Andrew D Weinberg
European Journal of Immunology
|
August 13, 2009
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
William L Redmond, Michael J Gough, Andrew D Weinberg
Journal of the American Medical Directors Association
|
June 13, 2006
Quality improvement case study: warfarin sodium interactions
Andrew D Weinberg, Julie S Altman, Jean K Pals
Critical Reviews in Immunology
|
June 23, 2009
The role of OX40-mediated co-stimulation in T-cell activation and survival
William L Redmond, Carl E Ruby, Andrew D Weinberg
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Journal of the American Medical Directors Association
|
June 17, 2003
Quality improvement case study: issues involving elopement of residents
Andrew D Weinberg, Alicia D Weinberg
Critical Reviews in Immunology
|
January 17, 2008
Targeting OX40 and OX40L for the treatment of autoimmunity and cancer
William L Redmond, Andrew D Weinberg
Cancer Immunology, Immunotherapy : CII
|
March 17, 2009
The effect of aging on OX40 agonist-mediated cancer immunotherapy
Carl E Ruby, Andrew D Weinberg
Nature Reviews. Immunology
|
June 3, 2004
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Kazuo Sugamura, Naoto Ishii, Andrew D Weinberg
Cancer Immunology Research
|
December 20, 2018
Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Fanny Polesso, Andrew D Weinberg, Amy E Moran
Immunology
|
May 15, 2012
Targeting macrophages in the tumour environment to enhance the efficacy of αOX40 therapy
Michael J Gough, N Killeen, Andrew D Weinberg
Journal of Immunology (Baltimore, Md. : 1950)
|
August 10, 2016
Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ
Amy E Moran, Fanny Polesso, Andrew D Weinberg
European Journal of Immunology
|
August 13, 2009
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
William L Redmond, Michael J Gough, Andrew D Weinberg
Journal of the American Medical Directors Association
|
June 13, 2006
Quality improvement case study: warfarin sodium interactions
Andrew D Weinberg, Julie S Altman, Jean K Pals
Critical Reviews in Immunology
|
June 23, 2009
The role of OX40-mediated co-stimulation in T-cell activation and survival
William L Redmond, Carl E Ruby, Andrew D Weinberg
Page
of 8